To investigate the cellular substrate(s) that link PD with chronic TBI, Western blot analysis was assessed in midbrain tissue 30 days post-TBI, using IκBα- and NF-κB- specific antibodies. The gene discussed is NFKB1; the disease is Parkinson disease.